BioInnovation Institute’s Post

View organization page for BioInnovation Institute, graphic

28,571 followers

Today, Kariya Pharmaceuticals, one of the very first companies BII supported, announced the successful dosing of the first cohort in a Phase 1 first-in-human trial for its lead compound, KP405, that can slow the progression of Parkinson's Disease.💊 According to Ian Laquian, CEO of Kariya Pharmaceuticals, receiving financial support at an early stage has been instrumental in bringing its lead compound one step closer to patients in need.📈   "First-in-human trials are momentous occasions for any organization, but today is extra special when you've been working on a concept for over a decade. There are so many people to thank and recognize on the way to this milestone, but none more important than the Novo Nordisk Foundation and the BioInnovation Institute." Matthias Wulf, Principal at BII, is pleased to see how far Kariya has come since receiving EUR 1.3M in financial support through BII's former Creation House program in 2019.   “It is fantastic to see how Kariya has moved their first-in-class treatment to the clinic to make a difference for people with Parkinson’s disease. It shows what good science and determined founders can achieve when they receive the proper support, he says." A huge congratulations to the Kariya team. We look forward to following your future progress to help people with Parkinson's disease.🚀 Christian Hölscher Bobby Soni Jens Nielsen Trine Bartholdy Sanne Brun Jensen Umar Adegoke Anders Østerby Mønsted Katrine Villarreal Villumsen #biotech #parkinsonsdisease #drugdevelopment #clinicaltrial #pharma #lifescience

  • No alternative text description for this image
Simon Kiddle

Life Sciences Patent Attorney, Partner at Mewburn Ellis LLP | Peptide Therapeutics, Antibody Technology, Protein Engineering, Next Generation Sequencing, Biologics Production and Purification, Microbiome, Green Tech

3mo

First in class treatment is an achievement indeed

Eliot Ward

Patent Attorney | Biotech | Diagnostics | Immunotherapy | Microbiome

3mo

Congratulations on taking this momentous step!

See more comments

To view or add a comment, sign in

Explore topics